Cotinga Pharmacueticals Provides Scientific and Business Update at Annual General Meeting and Announces Unit Offering – Nasdaq

TORONTO and BOSTON, March 19, 2019– Cotinga Pharmaceuticals Inc., a clinical stage biopharmaceutical company advancing a pipeline of targeted.